Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin + etoposide versus cisplatin + paclitaxel in advanced non-small cell lung cancer
TCTR20181011005Phase 3Completed
- Sponsor
- Dr. Munshi Md. Arif Hosen
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin, etoposide, paclitaxel in non-small cell lung cancer (NSCLC), sponsored by Dr. Munshi Md. Arif Hosen. Started Jan 2017; status: completed.
02
Drugs
cisplatinetoposidepaclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on TCTR20181011005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20181011005.